Pathogen spectrum, clinical traits and exploration of mortality outcome-improving medication regimens in coinfection patients with severe fever with thrombocytopenia syndrome: a multicenter cohort study
This study found a high proportion of SFTS patients with coinfection, which significantly worsens their clinical prognosis. SFTS currently has no specific therapy; clinical treatment focuses on symptomatic and supportive care, with strict standardization for antibiotics and antifungal use, and attention to patients' nutritional support. Albumin is a key protective factor associated with a lower risk of coinfection in SFTS patients; combined use of human albumin and corticosteroids was associated with a further trend toward better clinical prognosis in coinfected patients.
Authors
- Qun Li (ORCID: https://orcid.org/0000-0001-6287-8415)
- Wei Zhou (ORCID: https://orcid.org/0000-0002-6748-6303)
- Yong Zhou (ORCID: https://orcid.org/0000-0002-7348-2376)
- Yuanni Liu (ORCID: https://orcid.org/0000-0002-9305-3405)
- Lianhe Lu (ORCID: https://orcid.org/0009-0003-7278-4537)
- Zhihai Chen (ORCID: https://orcid.org/0000-0001-6481-4781)
- Chao Zhao (ORCID: https://orcid.org/0000-0001-7349-306X)
- Ling Lin (ORCID: https://orcid.org/0000-0001-6811-0968)
- Wei Zhang (ORCID: https://orcid.org/0000-0002-3169-4442)
- Zibo Fan
- Jianping Duan
- Yi Shen (ORCID: https://orcid.org/0000-0002-5311-9756)
- Zhenghua Zhao (ORCID: https://orcid.org/0000-0003-1042-9145)
Institutions
- Qingdao University (CN)
- Beijing Anding Hospital (CN)
- Qingdao Municipal Hospital (CN)
- Yantaishan Hospital (CN)
- Beijing Ditan Hospital (CN)
- Taian City Central Hospital (CN)
- Qingdao Eighth People's Hospital (CN)
- Seventh People's Hospital of Dalian (CN)
- Eastern Liaoning University (CN)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2025-11-21
- DOI
- https://doi.org/10.3389/fcimb.2025.1708979
- Citations
- 1
- Primary Topic
- Viral Infections and Vectors
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- National Natural Science Foundation of China